[Establishment of monoclonal antibody mNI-11 which induces homotypic cell aggregation of LPS-treated U937 cells].
A mouse monoclonal antibody (mAb), designated as mNI-11, was produced. The reactivity of mNI-11 was assessed by immunofluorescence assay with various cells. Myelomonocytic cell line, U937, and lipopolysaccharide (LPS)-treated U937 (LPS-U937 cells) were found to bind strongly to the mAb. EBV-B cell line and peripheral blood mononuclear cells (PBMCs) were found to bind moderately to it. This mAb strongly induced homotypic cell aggregation of LPS-U937 cells. The mAbs to CD18 and CD54 completely inhibited the LPS-U937 cell aggregation induced by mNI-11. The surface antigens of the U937 and LPS-U937 cells recognized by mNI-11 had a molecular size of 95-97 kDa as determined by immunoblotting analysis.